Nanexa AB Asset Resilience Ratio

Latest as of June 2026: 30.84%

Nanexa AB asset resilience ratio. Nanexa AB (NANEXA) has an Asset Resilience Ratio of 30.84% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Nanexa AB defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

Skr47.71 Million

≈ $5.13 Million USD Cash + Short-term Investments

Total Assets

Skr154.68 Million

≈ $16.65 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of Nanexa AB (2020–2025)

Asset resilience ratio of Nanexa AB from 2020 to 2025. This chart shows how Nanexa AB's Asset Resilience Ratio has changed over time. Read NANEXA total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Nanexa AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Nanexa AB asset portfolio.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr0.00	0%
Short-term Investments	Skr47.71 Million	30.84%
Total Liquid Assets	Skr47.71 Million	30.84%

Asset Resilience Insights

Very High Liquidity: Nanexa AB maintains exceptional liquid asset reserves at 30.84% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Nanexa AB Industry Peers by Asset Resilience Ratio

Compare Nanexa AB's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Sandoz Group AG SW:SDZ	Drug Manufacturers - Specialty & Generic	7.89%
H Lundbeck A/S CO:HLUN-B	Drug Manufacturers - Specialty & Generic	-0.56%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	47.16%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Viyash Scientific Limited NSE:SEQUENT	Drug Manufacturers - Specialty & Generic	0.08%
Anhui Fengyuan Pharmaceutical Co Ltd SHE:000153	Drug Manufacturers - Specialty & Generic	1.81%

Nanexa AB Asset Resilience Ratio by Year (2020–2025)

Nanexa AB asset resilience ratio by year from 2020 to 2025. The table below shows the annual Asset Resilience Ratio data for Nanexa AB.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	26.35%	Skr36.40 Million ≈ $3.92 Million	Skr138.14 Million ≈ $14.87 Million	-11.46pp
2023-12-31	37.81%	Skr50.00 Million ≈ $5.38 Million	Skr132.26 Million ≈ $14.23 Million	+37.81pp
2022-12-31	0.00%	Skr-1.00K ≈ $-107.62	Skr170.19 Million ≈ $18.32 Million	+0.02pp
2021-12-31	-0.02%	Skr-31.00K ≈ $-3.34K	Skr165.00 Million ≈ $17.76 Million	+0.17pp
2020-12-31	-0.19%	Skr-100.00K ≈ $-10.76K	Skr53.69 Million ≈ $5.78 Million	--

pp = percentage points

About Nanexa AB

ST:NANEXA Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$207.21 Million

Skr1.93 Billion SEK

Market Cap Rank

#16218 Global

#268 in Sweden

Share Price

Skr10.42

Change (1 day)

-0.76%

52-Week Range

Skr1.61 - Skr12.16

All Time High

Skr15.20